Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Cancer risk and use of common medications
Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013;158(5 Pt 1):312-20. doi: 10.7326/0003-4819-158-5-201303050-00003. PubMed
Nekhlyudov L, Greene SM, Chubak J, Rabin B, Tuzzio L, Rolnick S, Field TS. Cancer Research Network: using integrated healthcare delivery systems as platforms for cancer survivorship research. J Cancer Surviv. 2013 Mar;7(1):55-62. doi: 10.1007/s11764-012-0244-8. Epub 2012 Dec 14. PubMed
Chubak J. What can epidemiology contribute to comparative effectiveness research? J Epidemiol Community Health. 2013;67:3 206-7. doi:10.1136/jech-2012-201682. Epub 2012 Nov 23. PubMed
Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient reported discontinuation of endocrine therapy and related side effects among women with early stage breast cancer. J Oncol Prac. Nov 1 2012:e149-57. PubMed
Laing S, Bogart A, Green B, Chubak J. Ps2-22: Exploring the course of psychological distress and perceived health status after receiving a positive fecal occult blood test result. Clin Med Res. 2012;10(3):181-2. PubMed
Henderson JA, Chubak J, O’Connell J, Ramos MC, Jensen J, Jobe, JB. Design of a randomized controlled trial of a web-based intervention to reduce cardiovascular disease risk factors among remote-dwelling American Indians. J Prim Prev. 2012 Aug;33(4):209-22. PubMed
Chubak J, Anderson ML, Saunders KW, Hubbard RA, Tuzzio L, Liss DT, Morales LS, Reid RJ. Predictors of 1-year change in patient activation among older adults with diabetes and heart disease. J Am Geriatr Soc. 2012 Jul;60(7):1316-21. doi: 10.1111/j.1532-5415.2012.04008.x. PubMed
There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones.
Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.
Read about it in News and Events.
Drs. Kamineni and Chubak are among leaders of 2 new large PROSPR awards from NCI for cervical and colorectal cancer screening research.
Read it in News and Events.